Learning more about the role of mitochondrial dysfunction in Parkinson’s to help develop better therapies
New, more effective treatments are urgently needed for the more than one million people living
PD-MitoQUANT
PD-MitoQUANT Principal Investigators organise conference on the pathophysiology of Parkinson’s disease
Prinicpal Investigators of the Innovative Medicines Initative’s PD-MitoQUANT project Olga Corti, Stéphane Hunot (both based
Highlights of PD-MitoQUANT Plenary Meeting
At the sunny coastal town of Herzeliya, Israel, over 35 participants from 8 countries across
Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague
On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second
Join the PD-MitoQUANT team!
Title: Post-Doctoral Position in Parkinson’s research Department: Physiology and Medical Physics, RCSI Tenure: Specified Purpose, Full time for
Neuronet Scientific Coordination Board meeting brings together project leaders
Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.